PROM1 and glioblastoma: Earlier studies characterized GBM “CSCs” as a subpopulation of cells isolated from dissociated tumors based on expression of certain markers (e.g., CD133), which were subsequently cultured in neural stem cell media, while marker-negative cells were considered non-CSCs, or “differentiated”, and cultured in 10% FBS.